REQUEST A DEMO
Total
USD $0.00
Search more companies

Sanofi-Aventis Ukraina Tov (Ukraine)

Main Activities: Pharmaceutical and Medicine Manufacturing | Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Sanofi-Aventis Ukraina Tov Profile Updated: September 11, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Russian Download a sample report

Sanofi-Aventis Ukraina Tov is based in Ukraine, with the head office in Kyiv. The enterprise currently operates in the Pharmaceutical and Medicine Manufacturing sector. Sanofi-Aventis Ukraina Tov was incorporated on December 26, 2007. 140 (2024) employees currently work for Sanofi-Aventis Ukraina Tov. From the latest financial highlights, Sanofi-Aventis Ukraina Tov reported a net sales revenue increase of 9.31% in Q12026. Its’ total assets recorded a negative growth of 2.06%.

Headquarters
48-50A Vul. Zhylianska
Kyiv; Kiev; Postal Code: 01033

Contact Details: Purchase the Sanofi-Aventis Ukraina Tov report to view the information.

Website: http://www.sanofi.ua

Basic Information
Total Employees:
Purchase the Sanofi-Aventis Ukraina Tov report to view the information.
Registered Capital:
Purchase the Sanofi-Aventis Ukraina Tov report to view the information.
Financial Auditors:
Purchase the Sanofi-Aventis Ukraina Tov report to view the information.
Incorporation Date:
December 26, 2007
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Sanofi-Aventis Ukraina Tov report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency UAH. Absolute financial data is included in the purchased report.
Net sales revenue
9.31%
Total Operating Revenue
10.98%
EBITDA
20.46%
Total Assets
-2.06%
Total Equity
-1.81%
Debt / Equity
-0.3%
Quick Ratio
0.23%
Cash Ratio
0.6%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?